XBiotech, Inc. (NASDAQ:XBIT) announced that the last patient in the Phase 1 portion of its ongoing clinical study had cleared the safety window for its novel antibody therapy, 514G3, for the treatment of all forms of Staphylococcus aureus infections, including Methicillin-resistant S. aureus (MRSA). The phase I dose escalation was thus completed with no dose limiting toxicities, and therefore the phase II portion of the trial will be conducted at the maximum administered dose.
On Tuesday XBiotech, Inc. (NASDAQ:XBIT) share price closed at $10.06. Its return on equity (ROE) is -35.70%. XBiotech, Inc. (NASDAQ:XBIT) is -66.74% away from its 52 week high and its 52 week range is $6.36 – 32.50.
Oxford Asset Management purchased a new position in Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 362,776 shares of the company’s stock, valued at approximately $3,454,000. Oxford Asset Management owned approximately 1.70% of Avalanche Biotechnologies at the end of the most recent quarter.
Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) traded 361970 shares and its share price increased 1.60% to close at $5.08. Company has 6.00% insider ownership. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) quarterly performance is -46.81% while its year to date (YTD) performance is -46.64%.
Koninklijke Philips N.V (NYSE:PHG) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued to investors. A number of other equities research analysts have also weighed in on PHG. JPMorgan Chase & Co. restated a “buy” rating on shares of Koninklijke Philips NV in a research note. Goldman Sachs restated a “buy” rating on shares of Koninklijke Philips NV in a research note.
On Tuesday shares of Koninklijke Philips N.V (NYSE:PHG) ended up at $28.24. This year Company’s Earnings per Share (EPS) growth is 77.80% and next year’s EPS growth is 31.76%. Beta of Koninklijke Philips N.V (NYSE:PHG) is 1.50 while company weekly performance is 0.61%.
On Mar 21, SEI Investments Co. (NASDAQ:SEIC) has announced that it has extended its contract for an additional three years with Danske Bank, the trading name of Northern Bank Limited and part of the Copenhagen-headquartered Danske Bank Group.
SEI Investments Co. (NASDAQ:SEIC) increased 2.82% to close at $42.95 on 29 March. Its return on assets (ROA) is 21.50% while return on investment (ROI) is 14.90%. SEI Investments Co. (NASDAQ:SEIC) price to sales (P/S) ratio is 5.27.
Shell Asset Management Co. bought a new position in Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 19,515 shares of the company’s stock, valued at approximately $1,421,000.
On 29 March Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) ended the day at $75.46. Company net profit margin stands at 16.50% whereas its return on equity (ROE) is 25.30%. Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) is -0.05% away from its 52 week high.